Altair Therapeutics was a biopharmaceutical company that focused on developing therapeutics to treat human respiratory diseases.
Altair Therapeutics is a biopharmaceutical company focused on developing therapeutics to treat human respiratory diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 2, 2010 | Series B | $17M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
AgeChem Venture Fund | — | Series B |